Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
innovation crawled date : 2021 - 08 - 16 save search
Harvest Health & Recreation Inc. Announces Sale Leaseback Transaction with Innovative Industrial Properties
Published: 2021-08-16 (Crawled : 21:00) - prnewswire.com
IIPR 4 | $93.62 -0.92% 0.01% 120K
|
Finance
|
| O: -0.77%
H: 0.34%
C: 0.19%
trial health
Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results
Published: 2021-08-16 (Crawled : 20:00) - marronebio.com
MBII | $0.7981 -20.19% 1.49%
|
Process Industries
|
| O: -7.53%
H: 1.96%
C: -11.11%
financial results results
Gold Mining Industry Forges New Innovative Paths to Generate Higher Yields
Published: 2021-08-16 (Crawled : 13:00) - prnewswire.com
NEM | $38.56 1.18% 0.55% 9.1M
|
Non-Energy Minerals
|
| O: -0.3%
H: 0.73%
C: 0.07%
KGC | $6.42 1.74% -0.31% 17M
|
Non-Energy Minerals
|
| O: 1.08%
H: 0.99%
C: -1.15%
GOLD | $16.7 1.34% 0.9% 24M
|
Non-Energy Minerals
|
| O: -1.01%
H: 1.24%
C: 0.4%
AU | $23.85 2.4% -1.13% 2.6M
|
Non-Energy Minerals
|
| O: 1.84%
H: 0.5%
C: -0.12%
GOLD | $16.7 1.34% 0.9% 24M
|
Non-Energy Minerals
|
| O: -1.01%
H: 1.24%
C: 0.4%
Marrone Bio Innovations Collaborates with Terramera to Enhance Product Performance and Expedite Novel Product Development
Published: 2021-08-16 (Crawled : 13:00) - marronebio.com
MBII | $0.7981 -20.19% 1.49%
|
Process Industries
|
| O: 1.4%
H: 1.38%
C: 0.69%
collaboration
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study
Published: 2021-08-16 (Crawled : 13:00) - biospace.com/
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.33%
H: 2.03%
C: 1.91%
INCY | $52.72 -0.94% -0.91% 2.1M
|
Health Technology
|
| O: 0.53%
H: 0.72%
C: 0.68%
therapy phase 3
Lightbridge Receives Notice of Allowance for a Key Patent from the Canadian Intellectual Property Office for its Innovative Fuel Design and Related Manufacturing Method
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
LTBR | $2.52 -3.08% -2.36% 85K
|
Commercial Services
|
| O: -0.65%
H: 3.15%
C: -1.15%
patent designation
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-08-16 (Crawled : 00:00) - prnewswire.com
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 0.33%
H: 2.03%
C: 1.91%
INCY | $52.72 -0.94% -0.91% 2.1M
|
Health Technology
|
| O: 0.53%
H: 0.72%
C: 0.68%
treatment therapy phase 3
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.